Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation

American Journal of Cardiology

Volumn 115, Issue 10, 2015, Pages 1415-1422

  Fauchier, Laurent ^a   Marijon, Eloi ^b,c   Defaye, Pascal ^d   Piot, Olivier ^e   Sadoul, Nicolas ^f   Perier, Marie Cecile ^c   Gras, Daniel ^g   Klug, Didier ^h   Algalarrondo, Vincent ⁱ   Bordachar, Pierre ^j   Deharo, Jean Claude ^k   Leclercq, Christophe ^l   Babuty, Dominique ^a   Boveda, Serge ^m  

^a UNIVERSITÉ DE TOURS   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d HÔPITAL MICHALLON   (France)

^e Centre Cardiologique du Nord   (France)

^f CHU NANCY BRABOIS   (France)

^g Nouvelles Cliniques Nantaises   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ Universite Paris Sud   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k TIMONE HOSPITAL   (France)

^l PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^m CLINIQUE PASTEUR   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL; SPIRONOLACTONE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART DEATH; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLACTIC SURGICAL PROCEDURE; RECIPIENT; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; ADOLESCENT; AGE; AGE DISTRIBUTION; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; FRANCE; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; REGISTER; RISK ASSESSMENT; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; YOUNG ADULT;

EID: 84928589218     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.031     Document Type: Article

References (27)

1. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
2. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, K.P. Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, W.E. Sanders, A. Schaechter, and J.H. Levine Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
3. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, M.O. Sweeney, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, D.P. Faxon, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, H.M. Krumholz, F.G. Kushner, B.W. Lytle, R.A. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, L.G. Tarkington, and C.W. Yancy ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
5. J.N. Ruskin, A.J. Camm, D.P. Zipes, A.P. Hallstrom, and M.E. McGrory-Usset Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients J Cardiovasc Electrophysiol 13 2002 38 43
6. D.S. Lee, J.V. Tu, P.C. Austin, P. Dorian, R. Yee, A. Chong, D.A. Alter, and A. Laupacis Effect of cardiac and noncardiac conditions on survival after defibrillator implantation J Am Coll Cardiol 49 2007 2408 2415
7. A.D. Krahn, S.J. Connolly, R.S. Roberts, M. Gent ATMA Investigators Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death Am Heart J 147 2004 837 840
8. D. Yung, D. Birnie, P. Dorian, J.S. Healey, C.S. Simpson, E. Crystal, A.D. Krahn, Y. Khaykin, D. Cameron, Z. Chen, and D.S. Lee Survival after implantable cardioverter-defibrillator implantation in the elderly Circulation 127 2013 2383 2392
9. M. Suleiman, I. Goldenberg, M. Haim, J.E. Schliamser, M. Boulos, M. Ilan, M. Swissa, N. Gavrielov-Yusim, T. Fuchs, G. Amit, and M. Glikson Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD Registry Heart Rhythm 11 2014 435 441
10. D.T. Huang, H.W. Sesselberg, S. McNitt, K. Noyes, M.L. Andrews, W.J. Hall, A. Dick, J.P. Daubert, W. Zareba, and A.J. Moss Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy J Cardiovasc Electrophysiol 18 2007 833 838
11. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B.G. White, D.W. DeVries, and A.M. Feldman Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
12. P. Santangeli, L. Di Biase, A. Dello Russo, M. Casella, S. Bartoletti, P. Santarelli, G. Pelargonio, and A. Natale Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators Ann Intern Med 153 2010 592 599
13. W. Grimm, A. Stula, J. Sharkova, P. Alter, and B. Maisch Outcomes of elderly recipients of implantable cardioverter defibrillators Pacing Clin Electrophysiol 30 Suppl 1 2007 S134 S138
14. C. Ermis, A.X. Zhu, L. Vanheel, R.N. Sakaguchi, K.G. Lurie, F. Lu, and D.G. Benditt Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators Europace 9 2007 270 274
15. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
16. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S.G. Priori, R. Sutton, D.J. van Veldhuisen, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, M. Tendera, S.D. Anker, J.J. Blanc, M. Gasparini, A.W. Hoes, C.W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, and A.J. Camm 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
17. D.S. Lee, A.D. Krahn, J.S. Healey, D. Birnie, E. Crystal, P. Dorian, C.S. Simpson, Y. Khaykin, D. Cameron, A. Janmohamed, R. Yee, P.C. Austin, Z. Chen, J. Hardy, and J.V. Tu Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database J Am Coll Cardiol 55 2010 774 782
18. I. Goldenberg, A.K. Vyas, W.J. Hall, A.J. Moss, H. Wang, H. He, W. Zareba, S. McNitt, and M.L. Andrews Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
19. A.E. Buxton, K.L. Lee, G.E. Hafley, L.A. Pires, J.D. Fisher, M.R. Gold, M.E. Josephson, M.H. Lehmann, and E.N. Prystowsky Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157
20. K.C. Bilchick, G.J. Stukenborg, S. Kamath, and A. Cheng Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death J Am Coll Cardiol 60 2012 1647 1655
21. J.B. van Rees, C.J. Borleffs, M.K. de Bie, T. Stijnen, L. van Erven, J.J. Bax, and M.J. Schalij Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
22. J.J. Germano, M. Reynolds, V. Essebag, and M.E. Josephson Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
23. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, and K.K. Holloman Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
24. N. Clementy, B. Pierre, B. Lallemand, O. Marie, E. Lemoine, P. Cosnay, L. Fauchier, and D. Babuty Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction Europace 14 2012 968 974
25. A.J. Moss, C. Schuger, C.A. Beck, M.W. Brown, D.S. Cannom, J.P. Daubert, N.A. Estes 3rd, H. Greenberg, W.J. Hall, D.T. Huang, J. Kautzner, H. Klein, S. McNitt, B. Olshansky, M. Shoda, D. Wilber, W. Zareba MADIT-RIT Trial Investigators Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
26. M. Gasparini, A. Proclemer, C. Klersy, A. Kloppe, M. Lunati, J.B. Ferrer, A. Hersi, M. Gulaj, M.C. Wijfels, E. Santi, L. Manotta, and A. Arenal Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial JAMA 309 2013 1903 1911
27. U. Mezu, E. Adelstein, S. Jain, and S. Saba Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death Am J Cardiol 108 2011 718 722